Hikma Pharma logo

Hikma Pharma

Stock
Stock
ISIN: GB00B0LCW083
Ticker: HIK
GB00B0LCW083
HIK

Price

Price

Historical dividends and forecast

All dividend data

Hikma Pharma has so far distributed $0.79 in 2024. The next dividend will be paid on 03.05.2025


$0.46

CHART BY

Frequently asked questions

What is Hikma Pharma's market capitalization?

The market capitalization of Hikma Pharma is $5.20B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Hikma Pharma's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Hikma Pharma is 18.48. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Hikma Pharma?

Hikma Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.269. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Hikma Pharma's stock?

Currently, 11 analysts cover Hikma Pharma's stock, with a consensus target price of $28.46. Analyst ratings provide insights into the stock's expected performance.

What is Hikma Pharma's revenue over the trailing twelve months?

Over the trailing twelve months, Hikma Pharma reported a revenue of $3.00B.

What is the EBITDA for Hikma Pharma?

Hikma Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $804.12M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Hikma Pharma?

Hikma Pharma has a free cash flow of $218.94M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Hikma Pharma's stock?

The 5-year beta for Hikma Pharma is 0.39. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Hikma Pharma have, and what sector and industry does it belong to?

Hikma Pharma employs approximately 8,967 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Hikma Pharma's shares?

The free float of Hikma Pharma is 154.11M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$5.20B

5Y beta

 
0.39

EPS (TTM)

 
$1.269

Free Float

 
154.11M

P/E ratio (TTM)

 
18.48

Revenue (TTM)

 
$3.00B

EBITDA (TTM)

 
$804.12M

Free Cashflow (TTM)

 
$218.94M

Pricing

1D span
$23.77$25.01
52W span
$21.60$27.93

Analyst Ratings

The price target is $28.46 and the stock is covered by 11 analysts.

Buy

7

Hold

3

Sell

1

Information

Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products, supported by its manufacturing facilities in the United States, Europe and Middle East/North Africa (MENA). It is also engaged in the finished dosage form (FDF) business and has a manufacturing facility in Cleveland, Ohio. The Branded segment supplies branded generics and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. The Generics segment supplies oral and other non-injectable generic and specialty products to the United States retail market, leveraging its manufacturing facility in Columbus, Ohio.

8,967

Biotechnology & Drugs

Health Care

Identifier

ISIN

GB00B0LCW083

Primary Ticker

HIK

Knockouts

Join the conversation